SM
GNCA
Sabby Management’s Genocea Biosciences, Inc. GNCA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-312,666
| Closed | -$716K | – | 120 |
|
2020
Q3 | $716K | Buy |
312,666
+187,354
| +150% | +$429K | 0.11% | 38 |
|
2020
Q2 | $288K | Sell |
125,312
-314,962
| -72% | -$724K | 0.06% | 31 |
|
2020
Q1 | $757K | Sell |
440,274
-98,085
| -18% | -$169K | 0.31% | 12 |
|
2019
Q4 | $1.11M | Buy |
538,359
+61,008
| +13% | +$126K | 0.31% | 5 |
|
2019
Q3 | $1.38M | Sell |
477,351
-16,824
| -3% | -$48.8K | 0.75% | 6 |
|
2019
Q2 | $1.94M | Buy |
+494,175
| New | +$1.94M | 2.44% | 5 |
|
2016
Q1 | – | Sell |
-156,134
| Closed | -$823K | – | 234 |
|
2015
Q4 | $823K | Sell |
156,134
-573,007
| -79% | -$3.02M | 0.05% | 91 |
|
2015
Q3 | $5M | Buy |
729,141
+560,561
| +333% | +$3.84M | 0.21% | 27 |
|
2015
Q2 | $2.32M | Buy |
168,580
+68,580
| +69% | +$942K | 0.08% | 52 |
|
2015
Q1 | $1.19M | Buy |
+100,000
| New | +$1.19M | 0.05% | 71 |
|